Selective treatment pressure in colon cancer drives the molecular profile of resistant circulating tumor cell clones
Open Access
- 8 February 2021
- journal article
- letter
- Published by Springer Science and Business Media LLC in Molecular Cancer
- Vol. 20 (1), 1-6
- https://doi.org/10.1186/s12943-021-01326-6
Abstract
The characterization of circulating tumor cells (CTCs) holds promises for precision medicine because these cells are an important clinical indicator of treatment efficacy. We established the first and still only nine permanent colon CTC lines from peripheral blood samples of a patient with metastatic colon cancer collected at different time points during treatment and cancer progression. The study objectives were (i) to compare the gene expression profiles of these CTC lines, and (ii) to determine the main features acquired during treatment. The number of upregulated genes was higher in the CTC lines obtained after treatment, indicating that they acquired properties to escape treatment pressure. Among these upregulated genes, some are involved in the mTOR and PI3K/AKT signaling pathways. Moreover, cytidine deaminase expression was significantly increased in the CTC lines obtained after failure of the first- and second-line 5-fluorouracile-based treatments, suggesting that these CTCs can eliminate this specific drug and resist to therapy. Several enzymes involved in xenobiotic metabolism also were upregulated after treatment, suggesting the activation of detoxification mechanisms in response to chemotherapy. Finally, the significant higher expression of aldolase B in four of the six CTC lines obtained after treatment withdrawal and cancer progression indicated that these clones originated from liver metastases. In conclusion, these CTC lines generated at different time points during treatment of metastatic colon cancer in a single patient are characterized by the deregulation of different genes that promote (i) drug resistance, (ii) xenobiotic and energy metabolism, and (iii) stem cell properties and plasticity.Keywords
Funding Information
- Institut National Du Cancer
This publication has 19 references indexed in Scilit:
- Aldolase B Overexpression is Associated with Poor Prognosis and Promotes Tumor Progression by Epithelial-Mesenchymal Transition in Colorectal AdenocarcinomaCellular Physiology and Biochemistry, 2017
- Molecular Portrait of Metastasis-Competent Circulating Tumor Cells in Colon Cancer Reveals the Crucial Role of Genes Regulating Energy Metabolism and DNA RepairClinical Chemistry, 2017
- High-throughput screening of rare metabolically active tumor cells in pleural effusion and peripheral blood of lung cancer patientsProceedings of the National Academy of Sciences of the United States of America, 2017
- Downregulation of ALDOB is associated with poor prognosis of patients with gastric cancerOncoTargets and Therapy, 2016
- Aldolase B inhibits metastasis through Ten–Eleven Translocation 1 and serves as a prognostic biomarker in hepatocellular carcinomaMolecular Cancer, 2015
- Establishment and Characterization of a Cell Line from Human Circulating Colon Cancer CellsCancer Research, 2015
- Macrophages mediate gemcitabine resistance of pancreatic adenocarcinoma by upregulating cytidine deaminaseOncogene, 2013
- PIK3CA Mutation Is Associated With Poor Prognosis Among Patients With Curatively Resected Colon CancerJournal of Clinical Oncology, 2009
- Colorectal cancer: metastatic patterns and prognosis.1993
- Colorectal CancerSouthern Medical Journal, 1993